Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | +2.53% |
|
-9.84% | -58.69% |
06-20 | SAB Biotherapeutics, Inc. has Changed its Name to SAB BIO | CI |
06-07 | Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.69% | 26.21M | |
+15.19% | 121B | |
+19.91% | 114B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- Baird Starts SAB Biotherapeutics at Outperform With $23 Price Target